Manchester Cancer Services
30 May 2013
Manchester Cancer Services
Establishment of the EurocanPlatform
Evolution of the EurocanPlatform
Institute Jules Bordet and the OECI
European Thoracic Oncology Platform
Integrating breast cancer genomics and proteomics
How do we design trials that improve outcome?
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence
Long-term effectiveness of SERMs for preventing breast cancer
Implementation of individualised treatment and the WINTHER trial
Importance of personalised medicine and the WIN Consortium
The role of physicians and researchers in the medical community